Oct 14, 2025 04:07PM

Oct 6, 2025 05:31PM

Jan 24, 2025 06:06AM

Dec 20, 2024 04:17PM

Oct 30, 2024 05:04PM

Oct 2, 2024 04:08PM

Sep 6, 2024 07:30AM Psyence Biomedical (PBM) Announces the Signing of a Conditional Binding Term Sheet for the Acquisition of Psilocybin-Based Drug Developer Clairvoyant

Sep 6, 2024 07:30AM

Sep 4, 2024 07:31AM

Sep 4, 2024 07:30AM

Aug 30, 2024 07:00AM

Aug 19, 2024 04:08PM

Aug 13, 2024 07:30AM

Jul 31, 2024 04:05PM Psyence Biomed Enters Into $25 Million Common Stock Purchase Agreement with White Lion Capital, LLC

Jul 26, 2024 09:30AM

Jul 24, 2024 04:05PM

Jul 3, 2024 08:34PM

Apr 17, 2024 08:00AM

Apr 17, 2024 08:00AM

Apr 16, 2024 11:01AM

Apr 8, 2024 08:00AM Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial

Mar 18, 2024 04:05PM

Mar 12, 2024 11:15AM

Mar 11, 2024 07:00AM

Mar 6, 2024 07:00AM

Mar 20, 2023 07:30AM

15,384 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All